Skip navigation

Limit Study Variability • Streamline Data Collection • Ensure Efficient CEC Review • Minimize Regulatory Approval Timelines

May 1-2, 2018
  • Philadelphia, PA

New FDA Keynote Announced!

Andrew Farb, MD
Medical Officer, Senior Reviewer
US Food and Drug Administration

Heading into our 4th year, join CBI’s endpoint adjudication community of over 260 professionals from pharmaceutical, biotech, medical device, CROs, AROs and clinical sites who have benefited from this event. Regardless of your therapeutic area, this 4th Annual event delivers strategic content and concrete takeaways to bring back to your organization.

Join your clinical peers at CBI’s 4th Annual Endpoint Adjudication and gain practical insights to manage the complex adjudication process for independent review committee selection and charter development, as well as compiling information from various sources to provident consistent, reliable and accurate data to be submitted for adjudication.


  • Adjudicator Panel —
    Gain insight from Adjudicators on Packet Creation Best Practices
  • Mock Packet Review Interactive Session
  • Therapeutic Area-Specific Case Studies and Discussion
  • Risk-Based Analytical Adjudication
  • Prove ROI through Adjudication and Approval Results
  • Overcome Global Endpoint Challenges
  • Adjudication Best Practices for Pharma, Device and
    Diagnostic Companies
  • Audit Readiness and Preparation for Regulatory Updates
  • Clarification of Discrepancies in the Adjudication Data Sets and
    an Understanding of What Makes a Good Database
  • Appropriate Methodologies for Handling Quality Control (QC)
    Aspects of Adjudication Data
  • Tackling Cost Containment Surrounding Adjudication Processes
    and Clinical Endpoint Committees (CEC)

Previous Attendee Acclaim:

Talks hit the sweet spot for my company’s needs.
Excellent Q&A.

Director, Medical Safety, Integra Life Sciences

Real life examples of frequently encountered issues in
the adjudication world were presented. We can all
benefit and learn from each other.

PVG Adjudication Manager, PPD

Valuable discussion between colleagues in the endpoint space, increased knowledge and great networking.

Associate Clinical Manager, QuintilesIMS

Third time attending, great to see content getting more robust with every year. One of the only conferences of its kind.

Associate Oversight Committees PM, CPC Clinical Research